Expenditures related to oncological benefits in Poland 2013-2021
State spending on oncology in Poland in 2021 will amount to 12 billion zloty, an increase of 5.3 percent compared to 2020.
Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Hospitals in Germany
Overview
4
- Basic Statistic Number of hospitals in Germany 2000-2023
- Basic Statistic Statutory health insurance spending: hospital treatments Germany 2000-2023
- Premium Statistic Hospitals in Germany from 2019 to 2023, by bed size category
- Premium Statistic Share of German hospitals in 2022, by sponsorship and state
Capacity and occupancy
5
- Basic Statistic Cases in German hospitals from 1998 to 2023
- Premium Statistic Hospital beds in Germany 1998 to 2023
- Premium Statistic Bed capacity utilization in German hospitals 1998-2023
- Premium Statistic Occupancy days in German hospitals from 1998 to 2023
- Premium Statistic Length of stay in German hospitals from 1992 to 2023
Expenses and subsidies
3
Personnel
4
- Premium Statistic Full-time employees in German hospitals from 1998 to 2023
- Premium Statistic Medical and non-medical employees in German hospitals from 1991 to 2023
- Premium Statistic Hospital employee numbers in Germany from 2016 to 2023, by occupation
- Premium Statistic Apprenticeships in German hospitals in 2023, by occupation
Public hospitals
6
- Premium Statistic Public general hospitals in Germany from 2005 to 2023
- Premium Statistic Cases at public general hospitals Germany from 2004 to 2023
- Premium Statistic Beds at public general hospitals Germany from 2004 to 2023
- Premium Statistic Public general hospital bed occupancy in Germany from 2004 to 2023
- Premium Statistic Occupancy days at public hospitals general Germany from 2004 to 2023
- Premium Statistic Length of stay at public general hospitals in Germany 2004-2023
Private hospitals
7
- Premium Statistic Private general hospitals in Germany from 2004 to 2023
- Premium Statistic Cases at private general hospitals Germany from 2004 to 2023
- Premium Statistic Beds in private general hospitals Germany from 2004 to 2023
- Premium Statistic Private general hospital bed occupancy capacity in Germany from 2004 to 2023
- Premium Statistic Occupancy days at private general hospitals Germany from 2004 to 2023
- Premium Statistic Private general hospitals length of stay Germany from 2004 to 2023
- Premium Statistic Leading private clinic operator revenues in Germany from 2007 to 2022
Non-profit hospitals
6
- Premium Statistic Non-profit general hospital numbers in Germany from 2004 to 2023
- Premium Statistic Cases at non-profit general hospitals in Germany from 2004 to 2023
- Premium Statistic Beds in non-profit general hospitals in Germany from 2004 to 2023
- Premium Statistic Non-profit general hospitals bed occupancy Germany from 2004 to 2023
- Premium Statistic Occupancy days at non-profit general hospitals in Germany from 2004 to 2023
- Premium Statistic Non-profit general hospitals: length of stay in Germany from 2004 to 2023
Further related statistics
9
- Doctor visits in Germany - number per capita 1991-2021
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Leading causes of death among the white population in the United States 2020-2021
Further Content: You might find this interesting as well
Statistics
- Doctor visits in Germany - number per capita 1991-2021
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Leading causes of death among the white population in the United States 2020-2021
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Twitter (@MZ_GOV_PL), & Twitter (@PremierRP). (February 4, 2021). Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty) [Graph]. In Statista. Retrieved November 22, 2024, from https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/
Twitter (@MZ_GOV_PL), und Twitter (@PremierRP). "Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty)." Chart. February 4, 2021. Statista. Accessed November 22, 2024. https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/
Twitter (@MZ_GOV_PL), Twitter (@PremierRP). (2021). Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty). Statista. Statista Inc.. Accessed: November 22, 2024. https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/
Twitter (@MZ_GOV_PL), and Twitter (@PremierRP). "Expenses on The Reimbursement of Oncological Medicines and Oncological Benefits in Poland from 2013 to 2021 (in Billion Zloty)." Statista, Statista Inc., 4 Feb 2021, https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/
Twitter (@MZ_GOV_PL) & Twitter (@PremierRP), Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty) Statista, https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/ (last visited November 22, 2024)
Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty) [Graph], Twitter (@MZ_GOV_PL), & Twitter (@PremierRP), February 4, 2021. [Online]. Available: https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/